Filomena Russo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Author Correction: Genetic background and window of exposure contribute to thyroid dysfunction promoted by low-dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice.
Journal: Scientific reports
Published: July 21, 2026
Real-Life Effectiveness, Safety, and Growth Outcomes of Dupilumab in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis: A Multicenter Retrospective Study from an Italian NPP Program.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 07, 2026
The patient journey in prurigo nodularis: what lies ahead.
Journal: Expert opinion on biological therapy
Published: April 01, 2026
Case Report: Erythema gyratum repens associated with adenomyosis and endometriosis: an immunological twist?
Journal: Frontiers in immunology
Published: March 20, 2026
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases.
Journal: Frontiers in immunology
Published: February 04, 2026
Dupilumab for infants with atopic dermatitis: Friendly administration tips to enhance adherence.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 16, 2026
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.
Journal: Frontiers in immunology
Published: January 15, 2026
Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study.
Journal: Frontiers in immunology
Published: December 18, 2025
Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study.
Journal: Clinical and experimental dermatology
Published: October 21, 2025
Unmasking the High Prevalence of Psychological Morbidity in Atopic Dermatitis-A Call for Routine Screening.
Journal: International journal of dermatology
Published: October 20, 2025
Atopic Dermatitis and Climate: Environmental Stressors and Care Strategies.
Journal: Dermatology and therapy
Published: September 04, 2025
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.
Journal: Hematological oncology
Published: September 02, 2025
Last Updated: 09/26/2026